Nicodemo A C, Araujo M R E, Ruiz A S, Gales A C
Department of Infectious Diseases, University of São Paulo Medical School, S.P., Brazil.
J Antimicrob Chemother. 2004 Apr;53(4):604-8. doi: 10.1093/jac/dkh128. Epub 2004 Feb 18.
The disc diffusion, Etest and agar dilution techniques were compared to evaluate the antimicrobial susceptibility profile of 70 Stenotrophomonas maltophilia isolates to seven antimicrobial agents. The S. maltophilia isolates were consecutively collected from May 2000 to May 2002 from individual patients, who were hospitalized in a private Brazilian hospital. The antimicrobial susceptibility tests were carried out and interpreted according to the National Committee for Clinical Laboratory Standards (NCCLS) recommendations. The Etest was carried out according to the manufacturer's instructions. There was good agreement among the distinct susceptibility testing results for chloramphenicol, doxycycline, gatifloxacin, trimethoprim-sulfamethoxazole and ticarcillin-clavulanate, suggesting that the disc diffusion and Etest methods are reliable for testing this group of antimicrobials against S. maltophilia. In contrast, a weak correlation was found between the disc diffusion and agar dilution techniques for testing polymyxin B and colistin with unacceptable very major error rates (18.1% and 22.7% for polymyxin B and colistin, respectively). Trimethoprim- sulfamethoxazole (MIC50, 0.06 mg/L; 98.5% susceptible) and gatifloxacin (MIC50, 0.12 mg/L; 98.5% susceptible) were the most potent antimicrobial agents tested against S. maltophilia isolates. In contrast, the worst in vitro activity was found for ticarcillin-clavulanate (MIC50, 16 mg/L; 59.1% susceptible). Although our results confirm that trimethoprim-sulfamethoxazole, gatifloxacin and doxycycline have an excellent in vitro activity against S. maltophilia, further clinical studies are necessary to evaluate the clinical efficacy of these compounds for the treatment of S. maltophilia infections, since no randomized controlled trials have been carried out and no correlation between the clinical response and susceptibility testing results has been reported.
比较了纸片扩散法、Etest法和琼脂稀释法,以评估70株嗜麦芽窄食单胞菌分离株对7种抗菌药物的抗菌药敏谱。这些嗜麦芽窄食单胞菌分离株于2000年5月至2002年5月从巴西一家私立医院住院的个体患者中连续收集。抗菌药敏试验按照美国国家临床实验室标准委员会(NCCLS)的建议进行并解释。Etest法按照制造商的说明进行。氯霉素、多西环素、加替沙星、甲氧苄啶-磺胺甲恶唑和替卡西林-克拉维酸的不同药敏试验结果之间具有良好的一致性,表明纸片扩散法和Etest法对于检测这组抗菌药物对嗜麦芽窄食单胞菌的药敏是可靠的。相比之下,在检测多粘菌素B和黏菌素时,纸片扩散法和琼脂稀释法之间发现相关性较弱,且非常大误差率不可接受(多粘菌素B和黏菌素分别为18.1%和22.7%)。甲氧苄啶-磺胺甲恶唑(MIC50,0.06mg/L;98.5%敏感)和加替沙星(MIC50,0.12mg/L;98.5%敏感)是检测嗜麦芽窄食单胞菌分离株时最有效的抗菌药物。相比之下,替卡西林-克拉维酸的体外活性最差(MIC50,16mg/L;59.1%敏感)。虽然我们的结果证实甲氧苄啶-磺胺甲恶唑、加替沙星和多西环素对嗜麦芽窄食单胞菌具有优异的体外活性,但由于尚未进行随机对照试验,且未报道临床反应与药敏试验结果之间的相关性,因此需要进一步的临床研究来评估这些化合物治疗嗜麦芽窄食单胞菌感染的临床疗效。